{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:08Z","timestamp":1787020748732,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cytogenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Down syndrome myeloid hyperplasia includes transient abnormal myelopoiesis (TAM) and the myeloid leukemia associated with Down syndrome (ML-DS). The mutation of\n                      <jats:italic>GATA1<\/jats:italic>\n                      gene is essential in the development of Down syndrome combined with TAM or ML-DS. Some patients with TAM are asymptomatic and may also present with severe manifestations such as hepatosplenomegaly and hydrops.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      We report two cases of prenatally diagnosed TAM. One case was a rare placental low percentage 21 trisomy mosiacism, resulting in the occurrence of a false negative NIPT. The final diagnosis was made at 36\u00a0weeks of gestation when ultrasound revealed significant enlargement of the foetal liver and spleen and an enlarged heart; the foetus eventually died in utero. We detected a placenta with a low percentage (5\u20138%) of trisomy 21 mosiacism by Copy Number Variation Sequencing (CNV-seq) and Fluorescence in situ hybridization (FISH). In another case, foetal oedema was detected by ultrasound at 31\u00a0weeks of gestation. Two foetuses were diagnosed with Down syndrome by chromosomal microarray analysis via umbilical vein puncture and had significantly elevated cord blood leucocyte counts with large numbers of blasts. The\n                      <jats:italic>GATA1<\/jats:italic>\n                      Sanger sequencing results suggested the presence of a [NM_002049.4(\n                      <jats:italic>GATA1<\/jats:italic>\n                      ):c.220G\u2009&gt;\u2009A (p. Val74Ile)] hemizygous variant and a [NM_002049.4(\n                      <jats:italic>GATA1<\/jats:italic>\n                      ):c.49dupC(p. Gln17ProfsTer23)] hemizygous variant of the\n                      <jats:italic>GATA1<\/jats:italic>\n                      gene in two cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>It seems highly likely that these two identified mutations are the genetic cause of prenatal TAM in foetuses with Down syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13039-023-00658-w","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T10:02:13Z","timestamp":1697709733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prenatal diagnosis of Down syndrome combined with transient abnormal myelopoiesis in foetuses with a GATA1 gene variant: two case reports"],"prefix":"10.1186","volume":"16","author":[{"given":"Hui","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"issue":"3","key":"658_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/mrdd.20157","volume":"13","author":"SL Sherman","year":"2007","unstructured":"Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev. 2007;13(3):221\u20137. https:\/\/doi.org\/10.1002\/mrdd.20157.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"12","key":"658_CR2","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","volume":"107","author":"GV Massey","year":"2006","unstructured":"Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW, Ravindranath Y, Dahl G, Weinstein HJ, Children\u2019s Oncology G. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children\u2019s Oncology Group (COG) study POG-9481. Blood. 2006;107(12):4606\u201313. https:\/\/doi.org\/10.1182\/blood-2005-06-2448.","journal-title":"Blood"},{"issue":"5","key":"658_CR3","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellstrom-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937\u201351. https:\/\/doi.org\/10.1182\/blood-2009-03-209262.","journal-title":"Blood"},{"issue":"24","key":"658_CR4","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1182\/blood-2013-07-515148","volume":"122","author":"I Roberts","year":"2013","unstructured":"Roberts I, Alford K, Hall G, Juban G, Richmond H, Norton A, Vallance G, Perkins K, Marchi E, McGowan S, Roy A, Cowan G, Anthony M, Gupta A, Ho J, Uthaya S, Curley A, Rasiah SV, Watts T, Nicholl R, Bedford-Russell A, Blumberg R, Thomas A, Gibson B, Halsey C, Lee PW, Godambe S, Sweeney C, Bhatnagar N, Goriely A, Campbell P, Vyas P, Oxford-Imperial Down Syndrome Cohort Study G. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood. 2013;122(24):3908\u201317. https:\/\/doi.org\/10.1182\/blood-2013-07-515148.","journal-title":"Blood"},{"issue":"4","key":"658_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/ijlh.13451","volume":"43","author":"A Panferova","year":"2021","unstructured":"Panferova A, Gaskova M, Nikitin E, Baryshev P, Timofeeva N, Kazakova A, Matveev V, Mikhailova E, Popov A, Kalinina I, Hachatrian L, Maschan A, Maschan M, Novichkova G, Olshanskaya Y. GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients. Int J Lab Hematol. 2021;43(4):713\u201323. https:\/\/doi.org\/10.1111\/ijlh.13451.","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"658_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng1566","volume":"37","author":"Z Li","year":"2005","unstructured":"Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat Genet. 2005;37(6):613\u20139. https:\/\/doi.org\/10.1038\/ng1566.","journal-title":"Nat Genet"},{"issue":"3","key":"658_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrg.2016.154","volume":"18","author":"SE Antonarakis","year":"2017","unstructured":"Antonarakis SE. Down syndrome and the complexity of genome dosage imbalance. Nat Rev Genet. 2017;18(3):147\u201363. https:\/\/doi.org\/10.1038\/nrg.2016.154.","journal-title":"Nat Rev Genet"},{"key":"658_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf6202","author":"E Wagenblast","year":"2021","unstructured":"Wagenblast E, Araujo J, Gan OI, Cutting SK, Murison A, Krivdova G, Azkanaz M, McLeod JL, Smith SA, Gratton BA, Marhon SA, Gabra M, Medeiros JJF, Manteghi S, Chen J, Chan-Seng-Yue M, Garcia-Prat L, Salmena L, De Carvalho DD, Abelson S, Abdelhaleem M, Chong K, Roifman M, Shannon P, Wang JCY, Hitzler JK, Chitayat D, Dick JE, Lechman ER. Mapping the cellular origin and early evolution of leukemia in Down syndrome. Science. 2021. https:\/\/doi.org\/10.1126\/science.abf6202.","journal-title":"Science"},{"issue":"1","key":"658_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00043426-200201000-00004","volume":"24","author":"F Al-Kasim","year":"2002","unstructured":"Al-Kasim F, Doyle JJ, Massey GV, Weinstein HJ, Zipursky A, Pediatric OG. Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol. 2002;24(1):9\u201313. https:\/\/doi.org\/10.1097\/00043426-200201000-00004.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"26","key":"658_CR10","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1182\/blood-2011-04-350017","volume":"118","author":"AS Gamis","year":"2011","unstructured":"Gamis AS, Alonzo TA, Gerbing RB, Hilden JM, Sorrell AD, Sharma M, Loew TW, Arceci RJ, Barnard D, Doyle J, Massey G, Perentesis J, Ravindranath Y, Taub J, Smith FO. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children\u2019s Oncology Group Study A2971. Blood. 2011;118(26):6752\u20139. https:\/\/doi.org\/10.1182\/blood-2011-04-350017.","journal-title":"Blood"},{"issue":"1","key":"658_CR11","doi-asserted-by":"publisher","first-page":"F67","DOI":"10.1136\/archdischild-2014-308004","volume":"101","author":"JA Tamblyn","year":"2016","unstructured":"Tamblyn JA, Norton A, Spurgeon L, Donovan V, Bedford Russell A, Bonnici J, Perkins K, Vyas P, Roberts I, Kilby MD. Prenatal therapy in transient abnormal myelopoiesis: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2016;101(1):F67-71. https:\/\/doi.org\/10.1136\/archdischild-2014-308004.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"7","key":"658_CR12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319. https:\/\/doi.org\/10.1038\/s41375-022-01613-1.","journal-title":"Leukemia"},{"issue":"11","key":"658_CR13","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Branford S, Bueso-Ramos CE, Cortes JE, Dal Cin P, DiNardo CD, Dombret H, Duncavage EJ, Ebert BL, Estey EH, Facchetti F, Foucar K, Gangat N, Gianelli U, Godley LA, Gokbuget N, Gotlib J, Hellstrom-Lindberg E, Hobbs GS, Hoffman R, Jabbour EJ, Kiladjian JJ, Larson RA, Le Beau MM, Loh ML, Lowenberg B, Macintyre E, Malcovati L, Mullighan CG, Niemeyer C, Odenike OM, Ogawa S, Orfao A, Papaemmanuil E, Passamonti F, Porkka K, Pui CH, Radich JP, Reiter A, Rozman M, Rudelius M, Savona MR, Schiffer CA, Schmitt-Graeff A, Shimamura A, Sierra J, Stock WA, Stone RM, Tallman MS, Thiele J, Tien HF, Tzankov A, Vannucchi AM, Vyas P, Wei AH, Weinberg OK, Wierzbowska A, Cazzola M, Dohner H, Tefferi A. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328. https:\/\/doi.org\/10.1182\/blood.2022015850.","journal-title":"Blood"},{"issue":"20","key":"658_CR14","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544.","journal-title":"Blood"},{"issue":"6","key":"658_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/a-1532-2016","volume":"233","author":"S Al-Kershi","year":"2021","unstructured":"Al-Kershi S, Golnik R, Flasinski M, Waack K, Rasche M, Creutzig U, Dworzak M, Reinhardt D, Klusmann JH. Recommendations for diagnosis and treatment of children with transient abnormal myelopoiesis (TAM) and myeloid leukemia in down syndrome (ML-DS). Klin Padiatr. 2021;233(6):267\u201377. https:\/\/doi.org\/10.1055\/a-1532-2016.","journal-title":"Klin Padiatr"},{"issue":"5","key":"658_CR16","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1182\/blood-2004-04-1563","volume":"104","author":"JW Taub","year":"2004","unstructured":"Taub JW, Mundschau G, Ge Y, Poulik JM, Qureshi F, Jensen T, James SJ, Matherly LH, Wechsler J, Crispino JD. Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome. Blood. 2004;104(5):1588\u20139. https:\/\/doi.org\/10.1182\/blood-2004-04-1563.","journal-title":"Blood"},{"issue":"5","key":"658_CR17","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.humpath.2013.12.014","volume":"45","author":"S Hoeller","year":"2014","unstructured":"Hoeller S, Bihl MP, Tzankov A, Chaffard R, Hirschmann P, Miny P, Kuhne T, Bruder E. Morphologic and GATA1 sequencing analysis of hematopoiesis in fetuses with trisomy 21. Hum Pathol. 2014;45(5):1003\u20139. https:\/\/doi.org\/10.1016\/j.humpath.2013.12.014.","journal-title":"Hum Pathol"},{"issue":"1","key":"658_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1182\/blood-2003-09-3219","volume":"103","author":"A Shimada","year":"2004","unstructured":"Shimada A, Xu G, Toki T, Kimura H, Hayashi Y, Ito E. Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome. Blood. 2004;103(1):366. https:\/\/doi.org\/10.1182\/blood-2003-09-3219.","journal-title":"Blood"},{"issue":"9","key":"658_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1365-2443.2009.01338.x","volume":"14","author":"R Shimizu","year":"2009","unstructured":"Shimizu R, Kobayashi E, Engel JD, Yamamoto M. Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant. Genes Cells. 2009;14(9):1119\u201331. https:\/\/doi.org\/10.1111\/j.1365-2443.2009.01338.x.","journal-title":"Genes Cells"},{"issue":"6306","key":"658_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/349257a0","volume":"349","author":"L Pevny","year":"1991","unstructured":"Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D\u2019Agati V, Orkin SH, Costantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 1991;349(6306):257\u201360. https:\/\/doi.org\/10.1038\/349257a0.","journal-title":"Nature"},{"issue":"Suppl 2","key":"658_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/stem.5530160710","volume":"16","author":"SH Orkin","year":"1998","unstructured":"Orkin SH, Shivdasani RA, Fujiwara Y, McDevitt MA. Transcription factor GATA-1 in megakaryocyte development. Stem Cells. 1998;16(Suppl 2):79\u201383. https:\/\/doi.org\/10.1002\/stem.5530160710.","journal-title":"Stem Cells"},{"issue":"1","key":"658_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng955","volume":"32","author":"J Wechsler","year":"2002","unstructured":"Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, Crispino JD. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32(1):148\u201352. https:\/\/doi.org\/10.1038\/ng955.","journal-title":"Nat Genet"},{"key":"658_CR23","doi-asserted-by":"publisher","first-page":"891214","DOI":"10.3389\/fgene.2022.891214","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Kalev-Zylinska ML. Advances in molecular characterization of myeloid proliferations associated with Down syndrome. Front Genet. 2022;13:891214. https:\/\/doi.org\/10.3389\/fgene.2022.891214.","journal-title":"Front Genet"},{"issue":"11","key":"658_CR24","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/ng.2759","volume":"45","author":"K Yoshida","year":"2013","unstructured":"Yoshida K, Toki T, Okuno Y, Kanezaki R, Shiraishi Y, Sato-Otsubo A, Sanada M, Park MJ, Terui K, Suzuki H, Kon A, Nagata Y, Sato Y, Wang R, Shiba N, Chiba K, Tanaka H, Hama A, Muramatsu H, Hasegawa D, Nakamura K, Kanegane H, Tsukamoto K, Adachi S, Kawakami K, Kato K, Nishimura R, Izraeli S, Hayashi Y, Miyano S, Kojima S, Ito E, Ogawa S. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet. 2013;45(11):1293\u20139. https:\/\/doi.org\/10.1038\/ng.2759.","journal-title":"Nat Genet"},{"issue":"1","key":"658_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/pbc.20066","volume":"44","author":"JD Crispino","year":"2005","unstructured":"Crispino JD. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia. Pediatr Blood Cancer. 2005;44(1):40\u20134. https:\/\/doi.org\/10.1002\/pbc.20066.","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"658_CR26","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ajmg.a.61748","volume":"182","author":"M Orozco-Vela","year":"2020","unstructured":"Orozco-Vela M, Corona-Rivera A, Cruz-Osorio RM, Mendoza-Maldonado L, Marquez-Mora A, Barba-Barba CC, Pena-Padilla C, Baldomero-Lopez A, Bobadilla-Morales L, Corona-Rivera JR. Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants. Am J Med Genet A. 2020;182(9):2085\u201393. https:\/\/doi.org\/10.1002\/ajmg.a.61748.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"658_CR27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.11622\/smedj.2016106","volume":"57","author":"SH Lum","year":"2016","unstructured":"Lum SH, Choong SS, Krishnan S, Mohamed Z, Ariffin H. GATA1 mutations in a cohort of Malaysian children with Down syndrome-associated myeloid disorder. Singapore Med J. 2016;57(6):320\u20134. https:\/\/doi.org\/10.11622\/smedj.2016106.","journal-title":"Singapore Med J"},{"issue":"6","key":"658_CR28","doi-asserted-by":"publisher","first-page":"532","DOI":"10.5546\/aap.2013.eng.532","volume":"111","author":"AP Mansini","year":"2013","unstructured":"Mansini AP, Rubio PL, Rossi JG, Gallego MS, Medina A, Zubizarreta PA, Felice MS, Alonso CN. Mutation characterization in the GATA-1 gene in patients with Down\u2019s Syndrome diagnosed with transient abnormal myelopoiesis or acute megakaryoblastic leukemia. Arch Argent Pediatr. 2013;111(6):532\u20136. https:\/\/doi.org\/10.5546\/aap.2013.eng.532.","journal-title":"Arch Argent Pediatr"},{"issue":"13","key":"658_CR29","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood-2008-11-190330","volume":"114","author":"DC Cabelof","year":"2009","unstructured":"Cabelof DC, Patel HV, Chen Q, van Remmen H, Matherly LH, Ge Y, Taub JW. Mutational spectrum at GATA1 provides insights into mutagenesis and leukemogenesis in Down syndrome. Blood. 2009;114(13):2753\u201363. https:\/\/doi.org\/10.1182\/blood-2008-11-190330.","journal-title":"Blood"},{"issue":"22","key":"658_CR30","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1182\/blood-2010-05-282426","volume":"116","author":"R Kanezaki","year":"2010","unstructured":"Kanezaki R, Toki T, Terui K, Xu G, Wang R, Shimada A, Hama A, Kanegane H, Kawakami K, Endo M, Hasegawa D, Kogawa K, Adachi S, Ikeda Y, Iwamoto S, Taga T, Kosaka Y, Kojima S, Hayashi Y, Ito E. Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia. Blood. 2010;116(22):4631\u20138. https:\/\/doi.org\/10.1182\/blood-2010-05-282426.","journal-title":"Blood"},{"key":"658_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cancergen.2020.04.003","volume":"244","author":"AS Roseman","year":"2020","unstructured":"Roseman AS, Blackburn PR, Bakshi S, Grady L, Abbott MA, Hassan S, Hunt J, Richardson M, Peterson JF, Nguyen P, Greipp PT, Singh R. Twin-to-twin transmission of transient abnormal myelopoiesis without constitutional trisomy 21: a case report. Cancer Genet. 2020;244:62\u20134. https:\/\/doi.org\/10.1016\/j.cancergen.2020.04.003.","journal-title":"Cancer Genet"}],"container-title":["Molecular Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-023-00658-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13039-023-00658-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-023-00658-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T00:33:09Z","timestamp":1700353989000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularcytogenetics.biomedcentral.com\/articles\/10.1186\/s13039-023-00658-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1186\/s13039-023-00658-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2565345\/v1","asserted-by":"object"}]},"ISSN":["1755-8166"],"issn-type":[{"value":"1755-8166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study was approved by the institutional review board of the ethics committee of Guangdong Women and Children\u2019s Hospital. Informed consent was obtained from the patients for the publication of this case report (202201276).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}